The Global Drug Device Combination Market size is expected to grow at an annual average of 5.3% during 2021-2027. A drug-device combination product is a medical device consisting of a device and active pharmaceutical ingredients that are physically or chemically bonded together as a “single entity”. These products lead to safe and effective management and treatment of many disorders due to accurate drug delivery, topical administration and individualized treatment. Major drug-device combination products include drug-eluting stents, infusion pumps, inhalers, transdermal delivery systems, and prefilled syringes. These technologically advanced products are used to manage and treat many chronic diseases such as cancer, diabetes, respiratory problems, cardiovascular disease, wound healing, and more.
A full report of Drug Device Combination Market available at: https://www.orionmarketreports.com/request-sample/?id=47725
The drug-device combination market is not fragmented and the key players in this market are Medtronic, Boston Scientific Corp., Edwards Life sciences Corp., Stryker Corp., QLT Inc.
Drug Device Combination Market – Segmentation
By Product
• Drug-eluting stent
• Infusion pump
• Photodynamic therapy
• Antimicrobial wound dressing
• Prefilled syringe
By Wound Type
• Cardiovascular disease
• Diabetes
• Respiratory problem
• Cancer treatment
• Antimicrobial application
• Other applications
By End User
• Hospital & clinic
• Ambulatory surgery center (ASC)
• Home care setting
• Other end users
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
